These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34893821)

  • 1. Incidence of Invasive Fungal Infections in Patients Initiating Ibrutinib and Other Small Molecule Kinase Inhibitors-United States, July 2016-June 2019.
    Gold JAW; Tolu SS; Chiller T; Benedict K; Jackson BR
    Clin Infect Dis; 2022 Aug; 75(2):334-337. PubMed ID: 34893821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of invasive fungal infections in patients with hematological malignancies receiving ibrutinib therapy in south-east Austria.
    Egger M; Gornicec M; Wölfler A; Lembeck AL; Tinchon C; Maderdonner M; Prattes J
    Med Mycol; 2022 Sep; 60(9):. PubMed ID: 36029283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of invasive fungal infections in patients with chronic lymphocytic leukemia receiving ibrutinib within the veteran's healthcare administration.
    Walker C; Horowitz A; Nooruddin Z; Frei CR
    J Oncol Pharm Pract; 2024 Jun; 30(4):673-677. PubMed ID: 37309168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive fungal infection incidence and risk factors in patients receiving ibrutinib in real-life settings: A nationwide population-based cohort study.
    Allouchery M; Brunet K; Tomowiak C; Singier A; Pambrun E; Pariente A; Bezin J; Pérault-Pochat MC; Salvo F
    Mycoses; 2024 Jan; 67(1):e13676. PubMed ID: 37984556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and associated risk factors for invasive fungal infections and other serious infections in patients on ibrutinib.
    Holowka T; Cheung H; Malinis M; Gan G; Deng Y; Perreault S; Isufi I; Azar MM
    J Infect Chemother; 2021 Dec; 27(12):1700-1705. PubMed ID: 34389223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory effect of ibrutinib: Reducing the barrier against fungal infections.
    Maffei R; Maccaferri M; Arletti L; Fiorcari S; Benatti S; Potenza L; Luppi M; Marasca R
    Blood Rev; 2020 Mar; 40():100635. PubMed ID: 31699465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Call for Action: Invasive Fungal Infections Associated With Ibrutinib and Other Small Molecule Kinase Inhibitors Targeting Immune Signaling Pathways.
    Chamilos G; Lionakis MS; Kontoyiannis DP
    Clin Infect Dis; 2018 Jan; 66(1):140-148. PubMed ID: 29029010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary invasive fungal infection in hospitalised patients with COVID-19 in the United States.
    Thompson GR; Miceli MH; Jiang J; Shortridge EF; Davies K; Gurumoorthy G; Kimura T
    Mycoses; 2023 Jun; 66(6):527-539. PubMed ID: 36808656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fungal Infections with Ibrutinib and Other Small-Molecule Kinase Inhibitors.
    Zarakas MA; Desai JV; Chamilos G; Lionakis MS
    Curr Fungal Infect Rep; 2019 Sep; 13(3):86-98. PubMed ID: 31555394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infections in patients with lymphoproliferative diseases treated with targeted agents: SEIFEM multicentric retrospective study.
    Marchesini G; Nadali G; Facchinelli D; Candoni A; Cattaneo C; Laurenti L; Fanci R; Farina F; Lessi F; Visentin A; Marchesi F; Prezioso L; Spolzino A; Tisi MC; Trastulli F; Picardi M; Verga L; Dargenio M; Busca A; Pagano L;
    Br J Haematol; 2021 Apr; 193(2):316-324. PubMed ID: 33058237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive Fungal Infections in Children with Leukemia: Clinical Features and Prognosis.
    Sezgin Evim M; Tüfekçi Ö; Baytan B; Ören H; Çelebi S; Ener B; Üstün Elmas K; Yılmaz Ş; Erdem M; Hacımustafaoğlu MK; Güneş AM
    Turk J Haematol; 2022 Jun; 39(2):94-102. PubMed ID: 34792308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive Aspergillosis of the Spleen in the setting of Ibrutinib use.
    Asawa P; Chahine Z; Vusqa U; Samhouri Y; Fazal S
    J Oncol Pharm Pract; 2022 Oct; 28(7):1654-1658. PubMed ID: 35253502
    [No Abstract]   [Full Text] [Related]  

  • 13. Invasive fungal infections amongst patients with acute-on-chronic liver failure at high risk for fungal infections.
    Verma N; Singh S; Taneja S; Duseja A; Singh V; Dhiman RK; Chakrabarti A; Chawla YK
    Liver Int; 2019 Mar; 39(3):503-513. PubMed ID: 30276951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Cancer.
    Varughese T; Taur Y; Cohen N; Palomba ML; Seo SK; Hohl TM; Redelman-Sidi G
    Clin Infect Dis; 2018 Aug; 67(5):687-692. PubMed ID: 29509845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Disseminated cryptococcosis during ibrutinib treatment for chronic lymphocytic leukemia].
    Kumekawa H; Watanabe D; Tamura K; Mizuchi D
    Rinsho Ketsueki; 2022; 63(1):62-65. PubMed ID: 35135954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monetary costs and hospital burden associated with the management of invasive fungal infections in Mexico: a multicenter study.
    Corzo-León DE; Perales-Martínez D; Martin-Onraet A; Rivera-Martínez N; Camacho-Ortiz A; Villanueva-Lozano H
    Braz J Infect Dis; 2018; 22(5):360-370. PubMed ID: 30395800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of invasive fungal infections in lung transplant recipients in Western Australia.
    Chang A; Musk M; Lavender M; Wrobel J; Yaw MC; Lawrence S; Chirayath S; Boan P
    Transpl Infect Dis; 2019 Jun; 21(3):e13085. PubMed ID: 30925010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and risk factors for invasive fungal infections during induction chemotherapy for newly diagnosed acute myeloid leukemia: A retrospective cohort study.
    Lien MY; Chou CH; Lin CC; Bai LY; Chiu CF; Yeh SP; Ho MW
    PLoS One; 2018; 13(6):e0197851. PubMed ID: 29883443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive fungal infection after heart transplantation: A 7-year, single-center experience.
    Echenique IA; Angarone MP; Gordon RA; Rich J; Anderson AS; McGee EC; Abicht TO; Kang J; Stosor V
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27943503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combat-Related Invasive Fungal Wound Infections.
    Rodriguez RCJ; Ganesan A; Shaikh F; Carson ML; Bradley W; Warkentien TE; Tribble DR
    Mil Med; 2022 May; 187(Suppl 2):34-41. PubMed ID: 35512377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.